Certified by Founder Lodge
Verve Ventures
Switzerland - Zürich, Zürich
INVESTOR
1 Disclosed Funding Rounds $3,500,000
322 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Verve Ventures is a network and technology-driven venture capital firm headquartered in Switzerland. Founded in 2010, Verve Ventures has grown to more than 45 team members and has become one
| Company | Date | Round | Raised |
|---|---|---|---|
 Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
 Minut |
March, 31 ,2022 | Series B | $14,000,000 |
 Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
 ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
 Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
 tozero |
September, 07 ,2022 | Pre-Seed | $3,500,000 |
| tozero |
September, 07 ,2022 | Pre-Seed | $3,500,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
 Code Intelligence |
June, 03 ,2022 | Series A | $12,000,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
 Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Minut |
March, 31 ,2022 | Series B | $14,000,000 |
| tozero |
September, 07 ,2022 | Pre-Seed | $3,500,000 |
| Code Intelligence |
June, 03 ,2022 | Series A | $12,000,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
 Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Code Intelligence |
June, 03 ,2022 | Series A | $12,000,000 |
| Minut |
March, 31 ,2022 | Series B | $14,000,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
 CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Minut |
March, 31 ,2022 | Series B | $14,000,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Code Intelligence |
June, 03 ,2022 | Series A | $12,000,000 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Minut |
March, 31 ,2022 | Series B | $14,000,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Minut |
March, 31 ,2022 | Series B | $14,000,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| tozero |
September, 07 ,2022 | Pre-Seed | $3,500,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Minut |
March, 31 ,2022 | Series B | $14,000,000 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| tozero |
September, 07 ,2022 | Pre-Seed | $3,500,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Code Intelligence |
June, 03 ,2022 | Series A | $12,000,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Code Intelligence |
June, 03 ,2022 | Series A | $12,000,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Code Intelligence |
June, 03 ,2022 | Series A | $12,000,000 |
| Minut |
March, 31 ,2022 | Series B | $14,000,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Code Intelligence |
June, 03 ,2022 | Series A | $12,000,000 |
| Minut |
March, 31 ,2022 | Series B | $14,000,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Minut |
March, 31 ,2022 | Series B | $14,000,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
 Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Minut |
March, 31 ,2022 | Series B | $14,000,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Code Intelligence |
June, 03 ,2022 | Series A | $12,000,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Minut |
March, 31 ,2022 | Series B | $14,000,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Code Intelligence |
June, 03 ,2022 | Series A | $12,000,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Minut |
March, 31 ,2022 | Series B | $14,000,000 |
| Minut |
March, 31 ,2022 | Series B | $14,000,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Minut |
March, 31 ,2022 | Series B | $14,000,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Minut |
March, 31 ,2022 | Series B | $14,000,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Minut |
March, 31 ,2022 | Series B | $14,000,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
 IRUBIS |
September, 03 ,2024 | Pre Series A | |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| IRUBIS |
September, 03 ,2024 | Pre Series A | |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
 Puraffinity |
September, 10 ,2024 | Unknown | $8,809,670 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| IRUBIS |
September, 03 ,2024 | Pre Series A | |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Puraffinity |
September, 10 ,2024 | Unknown | $8,809,670 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| IRUBIS |
September, 03 ,2024 | Pre Series A | |
| IRUBIS |
September, 03 ,2024 | Pre Series A | |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Multiomic Health |
May, 05 ,2023 | Seed | $6,307,750 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| IRUBIS |
September, 03 ,2024 | Pre Series A | |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
 Phlair |
September, 19 ,2024 | Seed | $16,202,010 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Puraffinity |
September, 10 ,2024 | Unknown | $8,809,670 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Phlair |
September, 19 ,2024 | Seed | $16,202,010 |
| Puraffinity |
September, 10 ,2024 | Unknown | $8,809,670 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| Puraffinity |
September, 10 ,2024 | Unknown | $8,809,670 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| IRUBIS |
September, 03 ,2024 | Pre Series A | |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Puraffinity |
September, 10 ,2024 | Unknown | $8,809,670 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
 Nuclera |
October, 17 ,2024 | Unknown | $75,000,000 |
| IRUBIS |
September, 03 ,2024 | Pre Series A | |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| Phlair |
September, 19 ,2024 | Seed | $16,202,010 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| IRUBIS |
September, 03 ,2024 | Pre Series A | |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Nuclera |
October, 17 ,2024 | Unknown | $75,000,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Orakl Oncology |
October, 04 ,2023 | Unknown | $3,147,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Phlair |
September, 19 ,2024 | Seed | $16,202,010 |
| Phlair |
September, 19 ,2024 | Seed | $16,202,010 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| IRUBIS |
September, 03 ,2024 | Pre Series A | |
| Puraffinity |
September, 10 ,2024 | Unknown | $8,809,670 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| ChargeX |
July, 07 ,2023 | Series B | $12,557,712 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
| CellVoyant |
February, 27 ,2024 | Seed | $9,644,590 |
| Phlair |
September, 19 ,2024 | Seed | $16,202,010 |
| Fractory |
November, 09 ,2023 | Unknown | $5,133,000 |
| Puraffinity |
September, 10 ,2024 | Unknown | $8,809,670 |
| Groover |
February, 14 ,2024 | Series A | $8,000,000 |
| Cubbit |
July, 18 ,2024 | Unknown | $12,500,000 |
| Turn2X |
July, 24 ,2023 | Seed | $4,765,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
IORGANBIO | $2,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
